Germany's Merck KGaA agreed to acquire U.S. biopharmaceutical company SpringWorks Therapeutics for around $3.9 billion, in a bid to expand its oncology and rare disease business.

Jon Smith spots a growth stock that's getting more praise and attention from analysts, with current forecasts not to be ...

Jon Smith talks through a couple of S&P 500 stocks that have fallen over 20% in the last year. But are the positive winds of change blowing?

You hand money to a new company to help it grow in exchange for a stake in the business. After a few years, once it is ...

Force Motors plans to grow at a rate of 40% for which it will require immense financial discipline and stability.

From Home Goods to His Royal Highness King Charles lll's purveyor, 15 places Los Angeles designers say they shop for rugs.

When Exxon Mobil and Chevron report first-quarter results this week, investors will be focused on how falling oil prices have ...

Reuters, the news and media division of Thomson Reuters, is the world’s largest multimedia news provider, reaching billions ...

How bad are things at Tesla? So bad that it would have lost money in the first three months of the year had it not been the sale of regulatory credits, credits that could be going away if the Trump ...

“It’s a dynamic time right now, and off-price is a good place to be in retail because consumers want the best value,” Chris Miller, a senior vice president of marketing and strategy, said earlier this ...

Reliance shares hit a 5-month high as strong Q4 earnings and retail growth lead analysts to raise target prices and maintain ...

Costco is a phenomenal business, but shares trade near peak valuation. Click here to see why I rate COST stock a Sell.